Image 11 (Image 01)
Imiquimod Cream
Product Images NDC 72162-2332
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 72162-2332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 16 (Image 02)
This text presents a figure showing the subject accountability in a clinical trial for external genital warts treatment using Imiquimod Cream. The figure includes important data such as the number of subjects enrolled, completed the treatment, and those who withdrew. It also mentions the number of subjects who remained clear after completing the treatment and the follow-up period. Overall, this figure provides valuable information on the outcomes and accountability of subjects in the study.*
Label (Lbl721622332)
This text describes a medication called Imiquimod Cream available in single-use packets. It includes the active ingredient Imiquimod 12.5mg and various inactive ingredients such as benzyl alcohol, cetyl alcohol, glycerin, and xanthan gum. The cream is for dermatologic use only and should not be used in the eyes. The package contains 24 single-use packets, each weighing 0.25g, with instructions for use, storage conditions, and contact information for more details.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
